PBM ▲ +4.3% - Psyence Biomedical Ltd. $PBM - Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development Psyence Biomedical shares rose 4.3% on news that the company has established Texas Ibogaine Research Corporation to advance its U.S. ibogaine development efforts. The move signals the company's expansion into domestic research operations for the psychedelic compound, which is being studied for potential therapeutic applications. 14-SEP-2026 07:00 AM ET